More than a month after Zimbabwe started administering Sinopharm, the Chinese-made COVID-19 vaccine, the country has struggled to surpass the 75,000 mark as some front-line health workers — including doctors and nurses — are skeptical about its efficacy.
After a sharp increase in COVID-19 cases over the last few months, the government is hoping for an uptick in numbers as the vaccination floodgates have now opened to almost everyone.
Related: Wary of coronavirus vaccines, some Chinese citizens are ‘opting out’
Last week, Zimbabwe’s Vice President Constantino Chiwenga tried to reassure citizens on national ZBC TV after getting his second Sinopharm jab.
“There is nothing [wrong with vaccines] and I am feeling good. Eventually, it is going to be another passport. When you go to the restaurant you shall be able to produce [proof of vaccine] and then everybody will be free.”
“I am feeling great. You can see I am dispensing with my work. No problem at all. Perceptions are very difficult to get around them. And some who have very little knowledge but have got quite convincing voices, they take people astray. There is nothing [wrong with vaccines] and I am feeling good. Eventually, it is going to be another passport. When you go to the restaurant you shall be able to produce [proof of vaccine] and then everybody will be free,” he said.
Since February, the Chinese government has donated thousands of Sinopharm and Sinovac vaccines to Zimbabwe, and around the world.
Vice President Chiwenga, who doubles as the country’s health minister, presented a rollout plan to Parliament in February, indicating that the government aimed to vaccinate 49,000 government health workers, about 4,200 medical staff in security services and customs and immigration as well as nearly 7,000 agriculture extension workers.
The government recently opened vaccinations to everyone after notable lethargy among front-line workers.
Related: Jordan includes refugees in its COVID-19 vaccination rollout
Dr. Johannes Marisa, head of the Medical and Dental Private Practitioners of Zimbabwe Association, explained why there are concerns about the Sinopharm vaccine among health personnel.
“Sinopharm was in stage three of clinical trials. Many people are worried that it has not yet completed the clinical trials, [and]… are worried about the safety of the Sinopharm vaccine, same with Sinovac.”
“Sinopharm was in stage three of clinical trials. Many people are worried that it has not yet completed the clinical trials, [and]… are worried about the safety of the Sinopharm vaccine, same with Sinovac,” he said, adding that popular religious leaders known as “prophets” in Zimbabwe have recently expressed vaccine hesitancy. “And remember the followership … — it has a negative impact on the uptake of the vaccine.”
Related: Serbia lets people choose their COVID-19 vaccine. Some call it a ‘political ballot’
“I find it very important to get vaccinated so that we can fight this virus together. As a health worker, I should not give this virus to patients and also protect myself from the virus from patients as well.”
“I find it very important to get vaccinated so that we can fight this virus together. As a health worker, I should not give this virus to patients and also protect myself from the virus from patients as well,” he said.
Freelance journalist Leopold Kudakwashe Munhende has been to the country’s main vaccination center several times — but just to report on the program.
“I have very little information about the vaccines themselves,” Munhende said. “I do not know the efficacy rate of any of the vaccines the government is importing. So, at the end of the day, it is just a question of: ‘Go and get vaccinated so that you do not die.’ More of a threat in a way. I will be vaccinated after I have noted my “guinea pigs” who have already been vaccinated, if they are OK, say up to June. Then I think I will get vaccinated then. This is just a personal decision,” Munhende said.
Related: The biggest challenge for vaccine workers in Pakistan? Staying alive.
Nearby, a recently wedded 24-year-old nurse carries on with her work but nods in agreement with Munhende. She declined an audio interview but told The World that she heard the Sinopharm vaccine was not good for those who planned on giving birth. Yet, there is no evidence to verify this claim.
Zimbabwe’s government says Sinopharm is 76% to 86% effective. Other governments are waiting for emergency-use authorization for Sinopharm from the World Health Organization.
Dr. Norman Matara, spokesman for the Zimbabwe Association for Doctors for Human Rights, is hopeful the government’s vaccine passport idea will help with vaccine hesitancy, citing Israel’s passport program.
“Even in Israel, they have successfully implemented this, where people who have been vaccinated and have that vaccination passport can actually go into pubs, supermarkets, restaurants and actually enjoy themselves. So, it’s something that can also be implemented here. We also need to continue [debunking] myths and misconceptions surrounding the vaccines. We also need to rope in influential people to rally behind the vaccine so that more people can get buy-in to wanting to get vaccinated,” Matara said.
COVAX — a WHO-led initiative to ensure the equitable distribution of vaccines around the world, will donate 75,000 vaccine doses to Zimbabwe, and some already arrived on Monday from India, which could further increase the vaccination rates.
“Government’s aim is to buy 10 million doses of vaccines to get 60% herd immunity,” Dr. John Mangwiro, Zimbabwe’s junior health minister, told journalists Wednesday.
With the vaccination now open to all who are willing, there is hope that citizens will show up for their jabs and reach that target by year’s end.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!